or Try an Advanced Search...

    Technical Analysis for QTRX - Quanterix Corporation

    Grade Last Price % Change Price Change
    F 15.56 -0.19% -0.03
    QTRX closed down 0.19 percent on Friday, April 26, 2024, on 69 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 7
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical QTRX trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    180 Bearish Setup Bearish Swing Setup -0.19%
    Outside Day Range Expansion -0.19%
    Wide Bands Range Expansion -0.19%
    Older End-of-Day Signals for QTRX ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 17 hours ago
    Possible Inside Day about 17 hours ago
    10 DMA Resistance about 20 hours ago
    Up 2% about 21 hours ago
    Up 1% about 21 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    QTRX Chart by TradingView
    Basic chart:

    Profile

    Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Disease Infectious Diseases Inflammation Urology Biomarkers Cardiology Neurology Quality Of Life Digital Health Digital Health Solution

    Is QTRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 1 Investing in Quanterix (NASDAQ:QTRX) a year ago would have delivered you a 111% gain
    Mar 21 Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
    Mar 6 Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag
    Mar 4 Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
    Mar 3 Quanterix Corporation (NASDAQ:QTRX) Just Released Its Annual Results And Analysts Are Updating Their Estimates
    Mar 3 Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript
    Mar 2 Quanterix Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
    Mar 1 Q4 2023 Quanterix Corp Earnings Call
    Mar 1 Quanterix Corporation (QTRX) Q4 2023 Earnings Call Transcript
    Feb 29 Quanterix GAAP EPS of -$0.33 misses by $0.02, revenue of $31.55M beats by $1.71M
    See more QTRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 29.7
    52 Week Low 12.17
    Average Volume 376,771
    200-Day Moving Average 23.82
    50-Day Moving Average 22.79
    20-Day Moving Average 18.62
    10-Day Moving Average 16.01
    Average True Range 1.10
    RSI (14) 21.88
    ADX 38.81
    +DI 11.07
    -DI 32.37
    Chandelier Exit (Long, 3 ATRs) 20.64
    Chandelier Exit (Short, 3 ATRs) 18.63
    Upper Bollinger Bands 24.22
    Lower Bollinger Band 13.02
    Percent B (%b) 0.23
    BandWidth 60.16
    MACD Line -2.20
    MACD Signal Line -2.09
    MACD Histogram -0.1045
    Fundamentals Value
    Market Cap 588.63 Million
    Num Shares 37.8 Million
    EPS -1.02
    Price-to-Earnings (P/E) Ratio -15.25
    Price-to-Sales 7.89
    Price-to-Book 2.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 16.30
    Resistance 3 (R3) 16.36 16.19 16.17
    Resistance 2 (R2) 16.19 16.00 16.15 16.13
    Resistance 1 (R1) 15.87 15.88 15.79 15.81 16.09
    Pivot Point 15.70 15.70 15.65 15.66 15.70
    Support 1 (S1) 15.38 15.51 15.30 15.32 15.03
    Support 2 (S2) 15.21 15.39 15.17 14.99
    Support 3 (S3) 14.89 15.21 14.95
    Support 4 (S4) 14.83